Spots Global Cancer Trial Database for Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
Official Title: A Phase 2, Multi-Center, Open Label Study Evaluating the Efficacy and Safety of Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
Study ID: NCT00780663
Interventions
Study Description
Brief Summary: This is a Phase 2, open-label, multicenter, efficacy and safety study of quarfloxin in patients with low or intermediate grade neuroendocrine cancer. The purpose of this study is to evaluate the rate of clinical benefit response to quarfloxin treatment including the reduction in secretory symptoms of flushing and/or diarrhea or the reduction quantifiable hormones or other biochemical tumor markers.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Birmingham Hematology and Oncology, Birmingham, Alabama, United States
Rocky Mountain Cancer Centers, Denver, Colorado, United States
Front Range Cancer Specialists, Fort Collins, Colorado, United States
, Ocala, Florida, United States
Southern New Mexico Cancer Center, Las Cruces, New Mexico, United States
Texas Oncology, Amarillo, Texas, United States
Texas Oncology, Dallas, Texas, United States
El Paso Cancer Treatment Center, El Paso, Texas, United States
Cancer Care Centers of South Texas, Kerrville, Texas, United States
UT Health Science Center, San Antonio, Texas, United States
Tyler Cancer Center, Tyler, Texas, United States
Virginia Mason Medical Center, Seattle, Washington, United States
Northwest Cancer Specialists, Vancouver, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
